Article Information
History
- July 23, 2020.
Article Versions
- Version 1 (June 19, 2020 - 06:21).
- You are currently viewing Version 2 of this article (July 23, 2020 - 12:12).
- View Version 3, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Ruijie Ling1,#,
- Yihan Yu1,
- Jiayu He2,
- Jixian Zhang1,
- Sha Xu1,
- Renrong Sun1,
- Wangcai Zhu1,
- Mingfeng Chen2,
- Tao Li2,*,
- Honglong Ji3,* and
- Huanqiang Wang2,*
- 1Hubei Provincial Hospital of Integrated Chinese & Western Medicine, Wuhan, Hubei, China
- 2National Institute of Occupational Health and Poison Control, Chinese Center for Disease Control and Prevention, Beijing, China
- 3Department of Cellular and Molecular Biology, University of Texas Health Science Centre at Tyler, Tyler, Texas, USA
- ↵*Corresponding authors: Huan-Qiang Wang, Ph.D. National Institute of Occupational Health and Poison Control, Chinese Center for Disease Control and Prevention, 29 Nanwei Road,Xicheng District, Beijing, 100010, China; E-mail: wanghq{at}niohp.chinacdc.cn; Hong-Long Ji, Ph.D. Department of Cellular and Molecular Biology, University of Texas Health Science Centre at Tyler, Tyler, Texas, USA; E-mail: James.ji{at}uthct.edu; Tao Li, M.D. National Institute of Occupational Health and Poison Control, Chinese Center for Disease Control and Prevention, Beijing, China; E-mail: litao{at}niohp.chinacdc.cn.
↵# These authors contributed equally to this work.
Posted July 23, 2020.
Seroprevalence and epidemiological characteristics of immunoglobulin M and G antibodies against SARS-CoV-2 in asymptomatic people in Wuhan, China
